Abstract
Hemolytic uremic syndrome, a serious complication of Shiga toxin—associated diarrhea, is rare before 6 months of age. Immunologic and nonimmunologic factors present in human milk may partially explain this observation. In prior studies, we have demonstrated that human milk contains Gb3the receptor for the B subunit of Shiga toxin, and also contains secretory IgA (sIgA) against the toxin. We therefore sought to determine the relative importance of milk glycolipid and toxin-specific sIgA in toxin binding. We studied two populations that differed in their frequency of exposure to Shiga toxin. Human milk samples obtained from healthy donors from Boston and Buenos Aires were separated by centrifugation into aqueous (antibody enriched) and cream (glycosphingolipid enriched) fractions. An emulsion of equal volumes of aqueous phase or cream layer of each sample and purified Shiga toxin was incubated, and the amount of free toxin present in each was determined by enzyme immunoassay. The cream layers bound 85% ± 2 (mean ± SE) (Argentina milk samples) and 86% ± 1 (Boston milk samples) of Shiga toxin. In contrast, the soluble fraction in samples from Buenos Aires, a population expected to frequently have antibodies to Shiga toxin, bound more toxin (48% ± 2) than did this fraction in samples from Boston, an area where toxin exposure is infrequent (30% ± 3) (P < 0.0001). Toxin-binding lipids present in human milk are biologically active and may contribute to the putative protective effect of human milk In a population frequently exposed to Shiga toxins (Argentina), protection may be due to both immune (sIgA), and non-immune (lipid) factors present in human milk In a population infrequently exposed to Shiga toxins, cream fraction—associated glycolipids represent the major toxin binding activity in human milk.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andersson B, Porras O, Hanson LA, Lagergard T, Svanborg-Eden C. Inhibition of attachement ofStreptococcus pneumoniaeandHaemophilus influenzaeby human milk and receptor oligosaccharides. J Infect Dis 1986;153:232–237.
Cleary TG, West MS, Ruiz-Palacios G, Winsor DK, Calva JJ, Guerrerro ML, Van R. Human milk secretory immunoglobulin A toShigellavirulence plasmid-coded antigens. J Pediatr 1991;118:34–38.
Gomez HF, Ho H, Shah S, Lopez EL, Cleary TG. Mapping epitopic regions of Shiga toxin B-subunit using milk secretory immunoglobulin A (sIgA). In: Karmali MA, Goglio AG, editors. Recent Advances in Verocytotoxin-producingEscherichia coltinfections. Amsterdam NY: Elsevier Science BV; 1994. pp. 345–347.
Lopez EL, Diaz M, Grinstein S, Devoto S, Mendilaharzu F, Murray BE, Ashkenazi S, Rubeglio E, Woloj M, Vasquez M, Turco M, Pickering LK, Cleary TG. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989;160:469–475.
Newburg DS, Pickering LK, McCluer RH, Cleary TG. Fucosylated oligosaccharides of human milk protect suckling mice from heat-stabile enterotoxin ofEscherichia colt.J Infect Dis 1990;162: 1075–1080.
Newburg DS, Ashkenazi S, Cleary TG. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. J Infect Dis 1992;166:832–836.
Newburg DS, Linhardt RJ, Ampofo SA, Yolken RH. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr 1995;125:419–424.
Newburg DS. Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria? J Nutr 1997;127(5 Suppl):980S–984S.
Otnaess AE, Laegreid A, Ertnesvag K. Inhibition of enterotoxin fromEscherichia coltandVibrio choleraeby gangliosides from human milk. Infect Immun 1983;40:563–569.
Prado D, Cleary TG, Pickering LK, Ericsson CD, Barlett AV 3rdDuPont HL, Johnson PC. The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis 1986;154:149–155.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herrera-Insua, I., Gomez, H.F., Diaz-Gonzalez, V.A., Chaturvedi, P., Newburg, D.S., Cleary, T.G. (2001). Human Milk Lipids Bind Shiga Toxin. In: Newburg, D.S. (eds) Bioactive Components of Human Milk. Advances in Experimental Medicine and Biology, vol 501. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1371-1_41
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1371-1_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5521-2
Online ISBN: 978-1-4615-1371-1
eBook Packages: Springer Book Archive